Rod-shaped polypeptide nanoparticles for siRNA delivery

Area of Science:

• Biomaterials Science
• Nanotechnology
• Gene Therapy

Background:

• Rod-shaped nanoparticles demonstrate superior cellular interactions compared to spherical counterparts.
• C-S-B triblock polypeptides (collagen-silk-oligolysine) enable 1D co-assembly with siRNA.
• Investigating novel nanoparticle systems for effective gene delivery is crucial for therapeutic advancements.

Purpose of the Study:

• To evaluate siRNA-encapsulating rod-shaped C-S-B nanoparticles as a gene delivery system.
• To assess the cellular uptake and gene silencing efficacy of these nanoparticles in cancer cells.
• To understand the intracellular fate and potential limitations of the C-S-B/siRNA complexes.

Main Methods:

• Synthesis of C-S-B triblock polypeptides and co-assembly with siRNA.
• Cellular uptake studies using HeLa cells to quantify nanoparticle internalization.
• Gene knockdown assessment by measuring messenger RNA (mRNA) levels of Plk1 (Plk1).
• Apoptosis assays to determine the therapeutic effect induced by gene silencing.

Main Results:

• C-S-B/siRNA nanoparticles demonstrated efficient delivery into HeLa cells.
• Significant dose-dependent messenger RNA (mRNA) knockdown of Plk1 was observed.
• Induced apoptosis, indicating successful gene silencing, although less effective than cationic lipid formulations.
• High co-localization of nanoparticles with lysosomes was identified as a factor influencing effectiveness.

Conclusions:

• Rod-shaped C-S-B nanoparticles are a promising non-toxic platform for siRNA delivery.
• Efficient cellular uptake and gene knockdown highlight their potential in cancer therapy.
• Addressing lysosomal trafficking requires future optimization of polypeptide sequences for improved therapeutic outcomes.